Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
glucocorticoid receptor antagonist |
| gptkbp:administeredBy |
oral
|
| gptkbp:CASNumber |
gptkb:1496510-51-0
|
| gptkbp:clinicalTrialPhase |
Phase 3
|
| gptkbp:developedBy |
gptkb:Corcept_Therapeutics
|
| gptkbp:hasMolecularFormula |
C27H25F3N2O3
|
| gptkbp:hasUNII |
6Z5B6HVF6O
|
| https://www.w3.org/2000/01/rdf-schema#label |
CORT118335
|
| gptkbp:indication |
gptkb:cancer
gptkb:Cushing's_syndrome adrenocortical carcinoma solid tumors |
| gptkbp:IUPACName |
(4S)-4-(4-fluorophenyl)-2,2-dimethyl-1-(4-(trifluoromethyl)phenyl)-1,3-dihydroisoquinoline-6-carboxylic acid
|
| gptkbp:molecularWeight |
482.5 g/mol
|
| gptkbp:PubChem_CID |
71587765
CHEMBL3544945 |
| gptkbp:synonym |
gptkb:Relacorilant
|
| gptkbp:target |
glucocorticoid receptor
|
| gptkbp:bfsParent |
gptkb:Miricorilant
|
| gptkbp:bfsLayer |
8
|